Home > Financial Ratios > MOREPEN LABORATORIES

MOREPEN LABORATORIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for MOREPEN LABORATORIES
Please provide your vote to see the results

MOREPEN LABORATORIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 12.3214.9610.9810.685.18

What is the latest EV/Core EBITDA ratio of MOREPEN LABORATORIES ?

The latest EV/Core EBITDA ratio of MOREPEN LABORATORIES is 12.32 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202412.32
Mar202314.96
Mar202210.98
Mar202110.68
Mar20205.18

How is EV/Core EBITDA of MOREPEN LABORATORIES Trending?

Years EV/Core EBITDA % Change
Mar2024 12.32
-17.65
Mar2023 14.96
36.25
Mar2022 10.98
2.81
Mar2021 10.68
106.18
Mar2020 5.18 -

Other Financial Ratios of MOREPEN LABORATORIES


Compare EV/Core EBITDA ratio of peers of MOREPEN LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MOREPEN LABORATORIES ₹3,436.0 Cr -1.6% -5% 9.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


MOREPEN LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MOREPEN LABORATORIES

-1.6%

-5%

9.2%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses